Brandon Monk

Brandon Monk is an accomplished executive in the biopharmaceutical industry with extensive experience in sales, marketing, and business leadership. Currently serving as Senior Vice President for both the U.S. Gastroenterology and U.S. Plasma Derived Therapies Business Units at Takeda since January 2019, Brandon has previously held significant roles at Shire, Baxalta, and Baxter International Inc., focusing on immunology and payer marketing. Early career experience includes positions at Eli Lilly and Company, where Brandon contributed to strategic pricing and marketing in various therapeutic areas. Brandon holds an MBA from MIT Sloan School of Management and a BA in Business Administration from Hanover College.